Yıl: 2012 Cilt: 12 Sayı: 3 Sayfa Aralığı: 233 - 240 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study

Öz:
Amaç: Enflamasyonun, hem hipertansiyona sebep olan mekanizmalarda, hem de hipertansiyonla birlikte ateroskleroza sebep olan mekanizmalar içerisinde role sahip olduğu bilinmektedir. Birçok çalışmada otonom sinir sistemi ile enflamatuvar sistem aktivasyonunun ilişkisi gösterilmiştir. Çalışmanın amacı hipertansif hastalarda enflamasyon ile kardiyak otonomik fonksiyonlar arasındaki ilişkiyi değerlendirmektir. Yöntemler: Hipertansiyon tanısı almış 121 hasta (ortalama yaş 59±11 yıl, 60 erkek) ile 34 sağlıklı gönüllü (ortalama yaş 58±11 yıl, 18 erkek) eninekesitli gözlemsel çalışmaya alındı. Tüm katılımcılardan 24 saatlik ambulatuvar elektrokardiyogram kayıtları alınarak analizleri Pathfinder programı ile yapıldı. Kalp hızı değişkenliğinin (KHD) zaman bağımlı parametreleri aynı program kullanılarak hesaplandı. Kalp hızı türbülansı (KHT) parametreleri olan türbülans başlangıcı (TO) ve türbülans eğimi (TR) otomatik olarak HRT programı ile hesaplandı. İstatistiksel analiz eşleştirilmemiş t-testi, Mann-Whitney U testi, tek-yönlü ANOVA, Kruskal-Wallis varyans analizi, Ki-kare testi ve Spearman korelasyon katsayısı analizi ile yapıldı. Hipertansiyon ile yüksek duyarlıklı C-reaktif protein (hs-CRP), KHD ve KHT arasındaki ilişki yaş ve kreatinin seviyesi gibi karıştırıcı değişkenler için düzeltildikten sonra analiz edildi. Bulgular: Sağlıklı gönüllüler ile karşılaştırıldığında, hastaların hs-CRP değerlerinde artış, KHD parametrelerinde hafif, KHT parametrelerinde ise belirgin bozulma tespit edildi [SDNN; 132±28 karşın 112±34 msn, RMSSD; 27 (23-35) karşın 22 (16-28) msn, TO; -2.80±2.15 karşın %-0.96±2.36, TS; 7.56 (5.24-10.60) karşın 4.65 (2.44-7.26) msn/RR, hepsi için p<0.01]. Hastaların hs-CRP değerlerine göre en yüksek tertilde olanların, orta ve düşük varitertilde olanlara göre tüm KHD ve KHT değerleri daha çok bozulmuş olarak gözlendi [SDNN; 93±34 msn, RMSSD; 17 (13-22) msn, TO; %0.03±2.22, TS; 2.43 (1.84-3.89) msn/RR, hepsi için p<0.05]. Korelasyon analizine göre hs-CRP ile KHD ve KHT parametreleri arasında güçlü bir ilişki saptandı (SDNN; r=-0.690, RMSSD; r=-0.277, TS; r:-0.417, TO; r=0.267, hepsi için p<0.05). Sonuç: Hipertansif hasta popülasyonunda kardiyak otonomik fonksiyonlardaki dengesizlik enflamasyon ile ilişkilidir. (Anadolu Kardiyol Derg 2012; 12: 233-40)
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi

Hipertansiyonda enflamasyon kardiyak otonomik fonksiyonlarda dengesizlik ile ilişkilidir: Gözlemsel bir çalışma

Öz:
Objective: Inflammation plays a role both in the mechanisms leading to hypertension alone and in the mechanisms leading to atherosclerosis with hypertension. Previous studies have shown the relationship between the autonomic functions and inflammatory system activation. The aim of the study was to evaluate the relationship between inflammation and cardiac autonomic functions in hypertensive patients. Methods: One hundred twenty one hypertensive patients (mean age 59±11 years, 60 male) and 34 healthy volunteers (mean age 58±11 years, 18 male) were included in the present cross-sectional observational study. The 24-hour ambulatory electrocardiogram recordings were taken using Pathfinder Software. The heart rate variability (HRV) analysis was performed using time domain parameters using the same software. Heart rate turbulence (HRT) parameters, turbulence onset and turbulence slope were calculated with HRT software. Statistical analysis was performed using unpaired t-test or Mann-Whitney U test, one-way ANOVA or Kruskal-Wallis analysis of variance, Chi-square test, and Spearman rank order correlation analysis. The association of hypertension with high sensitivity C-reactive protein (hs-CRP), HRV and HRT was analyzed after adjustment for confounding variables as age and creatinine levels. Results: The mean hs-CRP was higher, HRV was slightly reduced while HRT was markedly blunted in hypertensive patients in comparison with control group [SDNN; 132±28 vs. 112±34 msec, RMSSD; 27 (23-35) vs. 22 (16-28) msec, TO; -2.80±2.15 vs. -0.96±2.36%, TS; 7.56 (5.24-10.60) vs. 4.65 (2.44-7.26) msec/RR, p<0.01 for all]. All of the HRV and HRT parameters were more deteriorated in the highest tertile hs-CRP group [SDNN; 93±34 msec, RMSSD; 17 (13-22) msec, TO; 0.03±2.22%, TS; 2.43 (1.84-3.89) msec/RR, p<0.05 for all]. There were correlations between hs-CRP and HRV and HRT parameters (SDNN; r=-0.690, RMSSD; r=-0.277, TS; r:-0.417, TO; r=0.267, p<0.05 for all). Conclusion: There is an inflammatory process in hypertensive patients and inflammation is related with unbalanced cardiac autonomic functions. (Anadolu Kardiyol Derg 2012; 12: 233-40)
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Ross T. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
  • 2. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-8.
  • 3. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 1998; 31: 1460-5.
  • 4. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005; 10: 88-101.
  • 5. Kudaiberdieva G, Gorenek B, Timuralp B. Heart rate variability as a predictor of sudden cardiac death. Anadolu Kardiyol Derg 2007; 7: 68-70.
  • 6. Huikuri HV, Jokinen V, Syvanne M, Nieminen MS, Airaksinen KE, Ikaheimo MJ, et al. For the Lipid Coronary Angioplasty Trial (LOCAT) study Group. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999; 19: 1979-85.
  • 7. Haarala A, Kahonen M, Eklund C, Jylhava J, Koskinen T, Taittonen L, et al. Heart rate variability is independently associated with C-reactive protein but not with serum amyloid A. The Cardiovascular Risk in Young Finns Study. Eur J Clin Invest 2011; 41: 951-7.
  • 8. von Kanel R, Carney RM, Zhao S, Whooley MA. Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease: findings from the Heart and Soul Study. Clin Res Cardiol 2011; 100: 241-7.
  • 9. Soares-Miranda L, Negrao CE, Antunes-Correa LM, Nobre TS, Silva P, Santos R, et al. High levels of C-reactive protein are associated with reduced vagal modulation and low physical activity in young adults. Scand J Med Sci Sports 2010 Jul 6. [Epub ahead of print].
  • 10. Lampert R, Bremner JD, Su S, Miller A, Lee F, Cheema F, et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008; 156: 759.e1-7.
  • 11. Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 2001; 12: 294-300.
  • 12. Lanza GA, Sgueglia GA, Cianflone D, Rebuzzi AG, Angeloni G, Sestito A, et al; SPAI (Stratificazione Prognostica dell'Angina Instabile Investigators). Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol 2006; 97: 1702-6.
  • 13. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25: 363-70.
  • 14. Araujo F, Antelmi I, Pereira AC, Latorre Mdo R, Grupi CJ, Krieger JE, et al. Lower heart rate variability is associated with higher serum highsensitivity C-reactive protein concentration in healthy individuals aged 46 years or more. Int J Cardiol 2006; 107: 333-7.
  • 15. Stein PK, Barzilay JI, Chaves PH, Traber J, Domitrovich PP, Heckbert SR, et al. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study. J Am Geriatr Soc 2008; 56: 315-21.
  • 16. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, et al. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol 2008; 52: 1353-65.
  • 17. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83: 356-62.
  • 18. Boos CJ, Lip GY. Is hypertension an inflammatory process? Curr Pharm Des 2006; 12: 1623-35.
  • 19. Levick SP, Murray DB, Janicki JS, Brower GL. Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension 2010; 55: 270-6.
  • 20. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117: 289-96.
  • 21. McDade TW, Hawkley LC, Cacioppo JT. Psychological and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med 2006; 68: 376-81.
  • 22. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462-536.
  • 23. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
  • 24. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354-81.
  • 25. Malik M, Wichterle D, Schmidt G. Heart rate turbulence. G Ital Cardiol 1999; 29: 65-69.
  • 26. Guzik P, Schmidt G. A phenomenon of heart-rate turbulence, its evaluation, and prognostic value. Card Electrophysiol Rev 2002; 6: 256-61.
  • 27. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999; 282: 2012-8.
  • 28. McGill HC Jr, McMahan CA, Tracy RE, Oalmann MC, Cornhill JF, Herderick EE, et al. Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 1998; 18: 1108-18.
  • 29. Stefanadi E, Tousoulis D, Androulakis ES, Papageorgiou N, Charakida M, Siasos G, et al. Inflammatory markers in essential hypertension: potential clinical implications. Curr Vasc Pharmacol 2010; 8: 509-16.
  • 30. Campelo M, Polonia J, Serrao P, Cerqueira-Gomes M. Evaluation of the sympathetic nervous system using heart rate variability and plasma hormones in hypertensive patients treated with cilazapril and atenolol. Cardiology 1996; 87: 402-8.
  • 31. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension 2003; 42: 1106-11.
  • 32. Okutucu S, Karakulak UN, Kabakcı G. Circadian blood pressure pattern and cardiac autonomic functions: different aspects of same pathophysiology. Anadolu Kardiyol Derg 2011; 11: 168-73.
  • 33. Poreba R, Derkacz A, Silber M, Andrzejak R. Assessment of cardiac arrhythmias in patients suffering from essential hypertension. Pol Arch Med Wewn 2004; 111: 183-9.
  • 34. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
  • 35. Marz P, Cheng JG, Gadient RA, Patterson PH, Stoyan T, Otten U, et al. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 1998; 95: 3251-6.
  • 36. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9.
  • 37. Singh P, Hawkley LC, McDade TW, Cacioppo JT, Masi CM. Autonomic tone and C-reactive protein: a prospective populationbased study. Clin Auton Res 2009; 19: 367-74.
  • 38. Lanza GA, Sgueglia GA, Angeloni G, Valsecchi S, Sestito A, Rebuzzi AG, et al; (Stratificazione Prognostica dell'Angina Instabile) Study Investigators. Prognostic value of heart rate turbulence and its relation to inflammation in patients with unstable angina pectoris. Am J Cardiol 2009; 103: 1066-72.
  • 39. Kop WJ, Stein PK, Tracy RP, Barzilay JI, Schulz R, Gottdiener JS. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 2010; 72: 626-35.
  • 40. Gupta V, Sachdeva S, Khan AS, Haque SF. Endothelial dysfunction and inflammation in different stages of essential hypertension. Saudi J Kidney Dis Transpl 2011; 22: 97-103.
  • 41. Tycinska AM, Mroczko B, Musial WJ, Sawicki R, Kaminski K, Borowska H, et al. Blood pressure in relation to neurogenic, inflammatory and endothelial dysfunction biomarkers in patients with treated essential arterial hypertension. Adv Med Sci 2011; 56: 80-7.
  • 42. Albert MA, Danielson E, Rifai N, Ridker PM; PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001; 286: 64-70.
  • 43. Lin LY, Lai LP, Lin JL, Du CC, Shau WY, Chan HL, et al. Tight mechanism correlation between heart rate turbulence and baroreflex sensitivity: sequential autonomic blockade analysis. J Cardiovasc Electrophysiol 2002; 13: 427-31.
  • 44. Watanabe MA. Heart rate turbulence: A review. IPEJ 2003; 3: 10-22.
  • 45. Kardeşoğlu E, Işılak Z, Yalcın M, Celik T. Autonomic nervous system in heart failure: an endless area of research/ The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction. Anadolu Kardiyol Derg 2011; 11: 373.
  • 46. Grimm W, Liedtke J, Muller HH. Prevalence of potential noninvasive arrhythmia risk predictors in healthy, middle-aged persons. Ann Noninvasive Electrocardiol 2003; 8: 37-46.
APA ÇELİK A, KOÇ F, KADI H, CEYHAN K, Erkorkmaz Ü (2012). Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. , 233 - 240.
Chicago ÇELİK ATAÇ,KOÇ FATİH,KADI Hasan,CEYHAN Köksal,Erkorkmaz Ünal Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. (2012): 233 - 240.
MLA ÇELİK ATAÇ,KOÇ FATİH,KADI Hasan,CEYHAN Köksal,Erkorkmaz Ünal Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. , 2012, ss.233 - 240.
AMA ÇELİK A,KOÇ F,KADI H,CEYHAN K,Erkorkmaz Ü Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. . 2012; 233 - 240.
Vancouver ÇELİK A,KOÇ F,KADI H,CEYHAN K,Erkorkmaz Ü Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. . 2012; 233 - 240.
IEEE ÇELİK A,KOÇ F,KADI H,CEYHAN K,Erkorkmaz Ü "Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study." , ss.233 - 240, 2012.
ISNAD ÇELİK, ATAÇ vd. "Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study". (2012), 233-240.
APA ÇELİK A, KOÇ F, KADI H, CEYHAN K, Erkorkmaz Ü (2012). Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. Anadolu Kardiyoloji Dergisi, 12(3), 233 - 240.
Chicago ÇELİK ATAÇ,KOÇ FATİH,KADI Hasan,CEYHAN Köksal,Erkorkmaz Ünal Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. Anadolu Kardiyoloji Dergisi 12, no.3 (2012): 233 - 240.
MLA ÇELİK ATAÇ,KOÇ FATİH,KADI Hasan,CEYHAN Köksal,Erkorkmaz Ünal Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. Anadolu Kardiyoloji Dergisi, vol.12, no.3, 2012, ss.233 - 240.
AMA ÇELİK A,KOÇ F,KADI H,CEYHAN K,Erkorkmaz Ü Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. Anadolu Kardiyoloji Dergisi. 2012; 12(3): 233 - 240.
Vancouver ÇELİK A,KOÇ F,KADI H,CEYHAN K,Erkorkmaz Ü Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study. Anadolu Kardiyoloji Dergisi. 2012; 12(3): 233 - 240.
IEEE ÇELİK A,KOÇ F,KADI H,CEYHAN K,Erkorkmaz Ü "Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study." Anadolu Kardiyoloji Dergisi, 12, ss.233 - 240, 2012.
ISNAD ÇELİK, ATAÇ vd. "Inflammation is related to unbalanced cardiac autonomic functions in hypertension: aAn observational study". Anadolu Kardiyoloji Dergisi 12/3 (2012), 233-240.